Table 6.

Immunization schedule

Vaccine	SoR/QoE	Relative to day of allo-HCT				12 months after first vaccination	Refresher	Comments	Ref
		Day +100	Month +6	Month +7	Month +8
Pneumococcus	AIIt	X	X	X		X	Unclear	Start with PCV13, after 12 months after first vaccination the 23 valent polysaccharide vaccine should be used	[269–270, 308]
Influenza	AII	X				X	Annually		[266, 271–276]
Polio inactivateda	AII		X	X	X	X	According to local health advisory	a Combination vaccine possible	[283–288, 309]
Pertussis (acellular)a	AIII		X	X	X	X			[277, 278, 309]
Diphtheria and tetanus toxoida	AII		X	X	X	X			[279–282, 292, 309]
Haemophilus influenzae a	BII		X	X	X	X			[269, 284, 288–295, 311, 312]
Meningococcal conjugate 4 valent and serogroup B	BII		X			X	None		[295, 313–315]
TBE	BIIt		X	X		X	5 years		[282, 316]
Hepatitis B	CII		X			X	Depending on titer	Combination vaccine possible (together with HAV)	[298-299, 317–320]
Mumps, measles, rubella	BII	Live attenuated vaccine after 24 months accordingly to the rule mentioned in Table 5					Unclear, depending on immune response	One dose is recommended	[301–303, 321, 322]
Varicella zoster virus (VZV)	BII								[304–307, 323]

^acombination vaccination possible